Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vanguard Intermediate Term Corporate Bond ETF (VCIT) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Vanguard Intermediate Term Corporate Bond ETFTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Vanguard Intermediate Term Corporate Bond ETF vs Health Care Select Sector SPDR Fund — how do they compare? Vanguard Intermediate Term Corporate Bond ETF trades at $81.28, while Health Care Select Sector SPDR Fund trades at $168.59. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Vanguard Intermediate Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.

VCITXLV
Sector
Fixed Income
52-Week High
$84.82$168.44
52-Week Low
$81.07$131.16

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Vanguard Intermediate Term Corporate Bond ETF

VCIT, the Vanguard Intermediate-Term Corporate Bond ETF, trades at $81.295 with a modest 0.28% daily gain. Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators remain neutral. The fund maintains competitive advantages with its ultra-low 0.03% expense ratio and approximately 5% yield, holding over 2,000 investment-grade corporate bonds. Recent dividend distributions of $0.33-0.34 highlight its income-focused strategy.

The outlook for VCIT remains favorable for income investors seeking corporate bond exposure with low costs. Key opportunities include the fund's yield advantage over treasury alternatives and consistent monthly distributions. Risks involve interest rate sensitivity and corporate credit quality concerns during economic uncertainty. Wall Street sentiment is generally positive given the fund's cost efficiency and diversification benefits.

Health Care Select Sector SPDR Fund

XLV, the Health Care Select Sector SPDR ETF, trades at $167.1, down 0.8% on the day. The technical outlook is bullish based on moving averages, though short-term oscillators signal overbought conditions. Recent news highlights the ETF's defensive appeal amid economic uncertainty and its competitive edge with a low 0.08% expense ratio. Strong healthcare earnings and investor inflows into defensive sectors support positive momentum.

The outlook for XLV is positive, driven by defensive sector demand and solid underlying holdings. Key opportunities include cost efficiency and diversification across 60 healthcare stocks. Risks involve sector-specific pressures like regulatory changes and liquidity challenges. Analyst sentiment remains favorable, with the ETF well-positioned for steady growth in a volatile market.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Vanguard Intermediate Term Corporate Bond ETF

VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.

Read more on VCIT

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV